Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01MD011322 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Minority Health and Health Disparities (NIMHD) | NIH |
| Wayne State University | OTHER |
| Alliant International University | OTHER |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test a prize-based contingency management intervention for increasing caregiver engagement in juvenile drug court and adolescent drug treatment, and for achieving the ultimate outcomes of reduced substance use and delinquent behavior among drug court-involved youth.
Juvenile offenders with substance abuse problems represent a large and underserved population that is at high risk of deleterious outcomes and long-term costs for themselves, their families, communities, and society. Moreover, a high percentage of substance abusing adolescents continue to abuse substances and engage in criminal activity into adulthood. Although one juvenile justice intervention, Juvenile Drug Court (JDC), has emerged as a promising model for reducing drug use and delinquency among youth, its effectiveness is variable. Drug court outcomes may be compromised by the lack of caregiver engagement in JDC processes and adolescent drug treatment. Incorporating easily implemented evidence-based incentive programs in JDCs might improve their effectiveness in reducing youth drug use and re-offending. An extensive body of research supports the critical role that families play in the etiology, maintenance, and treatment of adolescent substance abuse. Although family-based interventions for adolescent substance abuse have been shown to be superior to other treatment modalities, parents must attend treatment and participate in meaningful ways for these superior outcomes to be realized. This randomized clinical trial will examine the efficacy of a prize-based contingency management intervention for increasing caregiver engagement (attendance and participation) in JDC and adolescent drug treatment. This caregiver contingency management intervention (CCM) will be compared with drug court treatment as usual (TAU). Increased caregiver participation is predicted to improve adolescent outcomes (decreased drug use and delinquent behavior). One hundred and eighty youth enrolled in JDC will be randomly assigned along with a parent/caregiver to TAU or CCM. Analyses will examine measures of caregiver engagement in JDC as well as youth substance use (urine drug screens) and delinquent activity. Results from this study will demonstrate the effectiveness of CCM procedures for increasing caregiver attendance and participation in JDC and adolescent drug treatment above and beyond drug court and usual care. If effective, the CCM approach may ultimately be used to enhance JDC outcomes, thereby reducing substance use and recidivism in juvenile offenders served by this promising juvenile justice intervention.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Caregiver Contingency Management + Usual Drug Court Treatment | Experimental | This group will receive a caregiver contingency management intervention plus the standard outpatient substance abuse treatment services provided at JDC. |
|
| Usual Drug Court Treatment | Active Comparator | This group will receive the standard outpatient substance abuse treatment services provided at JDC. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Caregiver Contingency Management + Usual Drug Court Treatment | Behavioral | In addition to receiving JDC treatment as usual described below, caregiver participants will receive prize draws for engaging in activities consistent with their adolescents' successful completion of the JDC program during the time the youth is actively involved in JDC and substance abuse treatment. Specific activities that may be reinforced include: attendance at drug court hearings; accompanying the youth to probation meetings; participating in home visits; attendance at the youth's drug treatment sessions; attendance at mental health provider meetings; attending groups for parents of youth with substance abuse issues; and completing other verifiable treatment-related activities. All activities will meet the goals of (directly or indirectly) enhancing caregiver participation in the JDC and/or treatment process. Caregivers will receive escalating chances for tangible reinforcers each week for completing up to 3 of the activities agreed upon by the caregiver and the therapist. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Positive Urine Drug Screens at 5 Months Post-baseline | This measure reflects the number of positive urine drug screens for THC, amphetamines, methamphetamines, opiates, cocaine, benzodiazepines, MDMA, and oxycodone collected from youth participants. Assessed at baseline and 5 months; data reported for 5-month time point | Baseline to 5 months |
| Frequency of Substance Use and Substance-related Problems Self-reported by Youth on the Global Appraisal of Individual Needs. | The GAIN Substance Frequency Scale assesses frequency of substance use over the past 90 days. Scores range from 0 (no use) to 90 (daily use). Higher scores indicate greater substance use severity. | Baseline, 5 months |
| Measure | Description | Time Frame |
|---|---|---|
| Changes From Baseline to 18 Months Post-baseline in Youth Arrests, Charges, and Convictions. | Number of youth arrests, charges, and convictions measured via official arrest records. | Baseline to 18 months |
| Changes From Baseline to 18 Months Post-baseline in Youth Delinquent Behaviors (Measured at 0, 3, 5, 6, 9, 12, and 18 Months). |
Not provided
Inclusion Criteria for youth:
Exclusion Criteria for youth:
Inclusion Criteria for caregivers:
Exclusion Criteria for caregivers:
Inclusion Criteria for therapists:
Exclusion Criteria for therapists:
Inclusion Criteria for Juvenile Drug Court Personnel:
Exclusion Criteria for Juvenile Drug Court Personnel:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Phillippe Cunningham, Ph.D. | Medical University of South Carolina | Principal Investigator |
| David Ledgerwood, Ph.D. | Wayne State University | Principal Investigator |
| Stacy Ryan, Ph.D. | The University of Texas Health Science Center at San Antonio | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Montgomer County Juvenile Court, 380 West Second Street | Dayton | Ohio | 45422 | United States | ||
| Nueces County Juvenile Court/Juvenile Treatment Court |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31679607 | Background | Ledgerwood DM, Cunningham PB. Juvenile Drug Treatment Court. Pediatr Clin North Am. 2019 Dec;66(6):1193-1202. doi: 10.1016/j.pcl.2019.08.011. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study enrolled adolescent-caregiver dyads. The reported enrollment (n=53) reflects dyads. Outcome and adverse event data were collected only for adolescents unless otherwise noted. Counts represent dyads. Individual counts for adolescents and caregivers were not separately tracked for milestones.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Caregiver Contingency Management + Usual Drug Court Treatment | This group will receive a caregiver contingency management intervention plus the standard outpatient substance abuse treatment services provided at JDC. Caregiver Contingency Management + Usual Drug Court Treatment: In addition to receiving JDC treatment as usual described below, caregiver participants will receive prize draws for engaging in activities consistent with their adolescents' successful completion of the JDC program during the time the youth is actively involved in JDC and substance abuse treatment. Specific activities that may be reinforced include: attendance at drug court hearings; accompanying the youth to probation meetings; participating in home visits; attendance at the youth's drug treatment sessions; attendance at mental health provider meetings; attending groups for parents of youth with substance abuse issues; and completing other verifiable treatment-related activities. All activities will meet the goals of (directly or indirectly) enhancing caregiver participation in the JDC and/or treatment process. Caregivers will receive escalating chances for tangible reinforcers each week for completing up to 3 of the activities agreed upon by the caregiver and the therapist. |
| FG001 | Usual Drug Court Treatment | This group will receive the standard outpatient substance abuse treatment services provided at JDC. Usual Drug Court Treatment: Standard outpatient substance abuse treatment services that a young person would receive while participating in JDC. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Baseline Measures were only collected for adolescents participants. They were not collected for Caregivers
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Caregiver Contingency Management + Usual Drug Court Treatment (Adolescents) | This group will receive a caregiver contingency management intervention plus the standard outpatient substance abuse treatment services provided at JDC. Baseline Measures is for the adolescent participants |
| BG001 |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With Positive Urine Drug Screens at 5 Months Post-baseline | This measure reflects the number of positive urine drug screens for THC, amphetamines, methamphetamines, opiates, cocaine, benzodiazepines, MDMA, and oxycodone collected from youth participants. Assessed at baseline and 5 months; data reported for 5-month time point | Posted | Number | participants | Baseline to 5 months |
|
Five months
Adverse event data were collected only for adolescent participants. No adverse event data were collected for caregivers.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Caregiver Contingency Management + Usual Drug Court Treatment (Adolescents) | This group will receive a caregiver contingency management intervention plus the standard outpatient substance abuse treatment services provided at JDC. Adverse Measures are for the adolescent participants |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Suicide attempt | Psychiatric disorders | Non-systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Emotional distress about prizes | Social circumstances | Non-systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Professor | Medcial University of South Carolina | 843-876-1840 | cunninpb@musc.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Sep 6, 2017 | Apr 22, 2025 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| Baylor University |
| OTHER |
Not provided
Not provided
Not provided
Not provided
|
| Usual Drug Court Treatment | Behavioral | Standard outpatient substance abuse treatment services that a young person would receive while participating in JDC. |
|
Frequency of delinquent behaviors self-reported by youth using the Self-Report Delinquency Scale. |
| Baseline to 18 months |
| Changes From Baseline to 18 Months Post-baseline in Caregiver Reports on Youth Internalizing Symptoms and Externalizing Behaviors (Measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 Months). | Frequency of youth's internalizing symptoms and externalizing behaviors measured with the Child Behavior Checklist (caregiver report). | Baseline to 18 months |
| Changes From Baseline to 18 Months Post-baseline in Youth Reports on Youth Internalizing Symptoms and Externalizing Behaviors (Measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 Months). | Frequency of youth's internalizing symptoms and externalizing behaviors measured with the Brief Problem Checklist (youth report). | Baseline to 18 months |
| Changes From Baseline to Post-treatment in Caregiver Substance Use Problems. | Frequency and severity of substance use problems self-reported by caregivers on the Addiction Severity Index. | Baseline through treatment completion, an average of 4 months |
| Changes From Baseline to Post-treatment in Caregiver Depressive Symptoms. | Frequency and severity of depressive symptoms self-reported by caregivers on the Beck Depression Inventory. | Baseline through treatment completion, an average of 4 months |
| Changes From Baseline to Post-treatment in Therapist-Family Working Alliance (Measured at 1, 2, 3, and 4 Months, as Well as Post-treatment). | Levels of alliance during treatment reported by therapists, caregivers, and youth on the Working Alliance Inventory. | Baseline through treatment completion, an average of 4 months |
| Changes From Baseline to Post-treatment in Caregiver Treatment Attendance and Activity Completion (Measured at 1, 2, 3, and 4 Months, as Well as Post-treatment). | Frequency of caregiver attendance at their youth's substance use treatment sessions and completion of therapeutic activities reported by therapists on the Session Tracking Sheet. | Baseline through treatment completion, an average of 4 months |
| Changes From Baseline to the End of JDC Involvement in Caregiver Attendance at JDC Sessions. | Frequency of caregiver attendance at their youth's JDC sessions reported by JDC personnel on the JDC Attendance Form. | Baseline through the end of JDC involvement, an average of 12 months |
| Rates of Treatment Completion. | Rates of youth treatment completion reported by therapists using the Treatment Termination Form. | Up to 4 months on average |
| Levels of Satisfaction With Treatment and JDC. | Levels of satisfaction with substance use treatment and JDC reported by caregivers and youth on the Client Satisfaction Questionnaire. | Up to 4 months on average |
| Changes From Baseline to Post-treatment in Caregiver Perceptions of Incentive Programs. | Ratings by caregivers on perceptions of incentive-based interventions as measured by the Provider Survey of Incentives. | Baseline through treatment completion, an average of 4 months |
| Changes From Baseline to 36 Months Post-baseline in Therapist and JDC Personnel Perceptions of Incentive Programs (Measured at 0, 12, 24, and 36 Months). | Ratings by therapists and JDC personnel on perceptions of incentive-based interventions as measured by the Provider Survey of Incentives. | Baseline to 36 months |
| Reports at Post-treatment on Youth and Caregiver Attitudes Toward Incentive Programs. | Youth and caregiver attitudes toward incentive programs as measured during qualitative interviews. | Up to 4 months on average |
| Changes From Baseline to 36 Months Post-baseline in Therapist and JDC Personnel Attitudes Toward Incentive Programs (Measured at 0, 12, 24, and 36 Months). | Therapist and JDC personnel attitudes toward incentive programs as measured during qualitative interviews. | Baseline to 36 months |
| Corpus Christi |
| Texas |
| 78415 |
| United States |
| Usual Drug Court Treatment (Adolescents) |
This group will receive the standard outpatient substance abuse treatment services provided at JDC. Baseline Measures is for the adolescent participants |
| BG002 | Total | Total of all reporting groups |
| Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| OG001 | Usual Drug Court Treatment | This group will receive the standard outpatient substance abuse treatment services provided at JDC. Usual Drug Court Treatment: Standard outpatient substance abuse treatment services that a young person would receive while participating in JDC. |
|
|
| Primary | Frequency of Substance Use and Substance-related Problems Self-reported by Youth on the Global Appraisal of Individual Needs. | The GAIN Substance Frequency Scale assesses frequency of substance use over the past 90 days. Scores range from 0 (no use) to 90 (daily use). Higher scores indicate greater substance use severity. | Posted | Mean | Standard Deviation | score on a scale | Baseline, 5 months |
|
|
|
| Secondary | Changes From Baseline to 18 Months Post-baseline in Youth Arrests, Charges, and Convictions. | Number of youth arrests, charges, and convictions measured via official arrest records. | Not Posted | Jan 2026 | Baseline to 18 months | Participants |
| Secondary | Changes From Baseline to 18 Months Post-baseline in Youth Delinquent Behaviors (Measured at 0, 3, 5, 6, 9, 12, and 18 Months). | Frequency of delinquent behaviors self-reported by youth using the Self-Report Delinquency Scale. | Not Posted | Baseline to 18 months | Participants |
| Secondary | Changes From Baseline to 18 Months Post-baseline in Caregiver Reports on Youth Internalizing Symptoms and Externalizing Behaviors (Measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 Months). | Frequency of youth's internalizing symptoms and externalizing behaviors measured with the Child Behavior Checklist (caregiver report). | Not Posted | Baseline to 18 months | Participants |
| Secondary | Changes From Baseline to 18 Months Post-baseline in Youth Reports on Youth Internalizing Symptoms and Externalizing Behaviors (Measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 Months). | Frequency of youth's internalizing symptoms and externalizing behaviors measured with the Brief Problem Checklist (youth report). | Not Posted | Baseline to 18 months | Participants |
| Secondary | Changes From Baseline to Post-treatment in Caregiver Substance Use Problems. | Frequency and severity of substance use problems self-reported by caregivers on the Addiction Severity Index. | Not Posted | Baseline through treatment completion, an average of 4 months | Participants |
| Secondary | Changes From Baseline to Post-treatment in Caregiver Depressive Symptoms. | Frequency and severity of depressive symptoms self-reported by caregivers on the Beck Depression Inventory. | Not Posted | Baseline through treatment completion, an average of 4 months | Participants |
| Secondary | Changes From Baseline to Post-treatment in Therapist-Family Working Alliance (Measured at 1, 2, 3, and 4 Months, as Well as Post-treatment). | Levels of alliance during treatment reported by therapists, caregivers, and youth on the Working Alliance Inventory. | Not Posted | Baseline through treatment completion, an average of 4 months | Participants |
| Secondary | Changes From Baseline to Post-treatment in Caregiver Treatment Attendance and Activity Completion (Measured at 1, 2, 3, and 4 Months, as Well as Post-treatment). | Frequency of caregiver attendance at their youth's substance use treatment sessions and completion of therapeutic activities reported by therapists on the Session Tracking Sheet. | Not Posted | Baseline through treatment completion, an average of 4 months | Participants |
| Secondary | Changes From Baseline to the End of JDC Involvement in Caregiver Attendance at JDC Sessions. | Frequency of caregiver attendance at their youth's JDC sessions reported by JDC personnel on the JDC Attendance Form. | Not Posted | Baseline through the end of JDC involvement, an average of 12 months | Participants |
| Secondary | Rates of Treatment Completion. | Rates of youth treatment completion reported by therapists using the Treatment Termination Form. | Not Posted | Up to 4 months on average | Participants |
| Secondary | Levels of Satisfaction With Treatment and JDC. | Levels of satisfaction with substance use treatment and JDC reported by caregivers and youth on the Client Satisfaction Questionnaire. | Not Posted | Up to 4 months on average | Participants |
| Secondary | Changes From Baseline to Post-treatment in Caregiver Perceptions of Incentive Programs. | Ratings by caregivers on perceptions of incentive-based interventions as measured by the Provider Survey of Incentives. | Not Posted | Baseline through treatment completion, an average of 4 months | Participants |
| Secondary | Changes From Baseline to 36 Months Post-baseline in Therapist and JDC Personnel Perceptions of Incentive Programs (Measured at 0, 12, 24, and 36 Months). | Ratings by therapists and JDC personnel on perceptions of incentive-based interventions as measured by the Provider Survey of Incentives. | Not Posted | Baseline to 36 months | Participants |
| Secondary | Reports at Post-treatment on Youth and Caregiver Attitudes Toward Incentive Programs. | Youth and caregiver attitudes toward incentive programs as measured during qualitative interviews. | Not Posted | Up to 4 months on average | Participants |
| Secondary | Changes From Baseline to 36 Months Post-baseline in Therapist and JDC Personnel Attitudes Toward Incentive Programs (Measured at 0, 12, 24, and 36 Months). | Therapist and JDC personnel attitudes toward incentive programs as measured during qualitative interviews. | Not Posted | Baseline to 36 months | Participants |
| 0 |
| 32 |
| 3 |
| 32 |
| 1 |
| 32 |
| EG001 | Usual Drug Court Treatment (Adolescents) | This group will receive the standard outpatient substance abuse treatment services provided at JDC. Adverse Measures are for the adolescent participants | 0 | 21 | 3 | 21 | 0 | 21 |
Not provided
Not provided
| Baseline - Days of alcohol use |
|
| Month 5 - Days drunk or high whole day |
|
| Month 5 - Days of marijuana use |
|
| Month 5 - Days of alcohol use |
|